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Background: Cold-induced injury to various cell types has been shown to be mediated predominantly by chelatable iron.
For endothelial cells, this type of injury has so far only been shown in cultured cells. Hypothesizing that this
iron-dependent cold-induced injury might also occur in the endothelium of intact vessels, we here set out to optimize the
hypothermic storage of blood vessels.
Methods: Segments of porcine aorta were stored for 2 to 21 days in histidine-tryptophan-ketoglutarate (HTK) solution or
in modified solutions with or without the iron chelators deferoxamine or LK 614 at 4°C. Parts of the segments were
assayed immediately after cold storage, the other parts after subsequent rewarming. The percentage of dead (propidium
iodide-positive) endothelial cells was assessed by “intravital” fluorescencemicroscopy, mitochondrial membrane potential
was assessed by laser scanning microscopy after staining with tetramethylrhodamine methyl ester (TMRM) and
thrombocyte adhesion was studied using 5-(and -6)-carboxy SNARF-1-stained thrombocytes.
Results: The endothelium of porcine aortic segments sustained moderate injury during the cold incubation itself, but
major injury during rewarming. The addition of the iron chelator deferoxamine (1 mmol/L) significantly inhibited
cold-induced endothelial cell injury irrespective of the solution used for cold storage (eg, 14 days of cold storage  3
hours rewarming: HTK 66  7%, HTK  1 mmol/L deferoxamine 40  10% propidium iodide-positive endothelial
cells). An amino acid (glycine, alanine, aspartate)-containing base solution withN-acetylhistidine as buffer was optimized.
The optimized base solution with pH 7.0 and potassium and chloride as main ions yielded a further decrease of
endothelial cell injury. Combination of deferoxamine (in lower concentration, ie, 0.1 mmol/L) with the new, more
membrane-permeable iron chelator LK 614 (20mol/L) further improved preservation so that even after 3 weeks of cold
storage plus 3 hours rewarming only 10  1% of endothelial cells were propidium iodide positive. In this optimized
solution, both endothelial cell survival and mitochondrial membrane potential were significantly better preserved than in
the clinically used solutions HTK, University of Wisconsin (UW) and Perfadex, or in physiological saline. Thrombocyte
adhesion was also significantly reduced after cold storage in the optimized solution compared with HTK solution.
Conclusion: Cold-induced injury to the endothelium of porcine aortic segments is, as the injury to cultured endothelial
cells, mediated by chelatable iron. Thus, iron chelators, but also optimized base solutions, are options to improve the
storage of vascular endothelium. The optimized solution should now be tested in in vivo animal experiments. ( J Vasc
Surg 2008;47:422-31.)
Clinical Relevance: In vascular and transplantation surgery, vessels are stored under hypothermic conditions to minimize cell
injury.However, hypothermia itself damages isolated endothelial cells by an iron-dependentmechanism.Here, we ascertained
that endothelial cells of intact vessels also suffer this injury, and then optimized cold storage of a model vascular graft (porcine
aorta) by inhibiting this injury. A vascular preservation solution was developed, which maintained the quality of the stored
grafts with regards to endothelial cell survival, mitochondrial membrane potential, and platelet adhesion much better than all
solutions currently used clinically, andwhich should nowbe further evaluated for prospective vessel storage in clinical settings.From the Institut für Physiologische Chemie, Universitätsklinikum.
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422Vascular homo- or allografts remain popular conduits for
reconstruction procedures in cardiovascular1-5 and trans-
plantation6-8 surgery. In cardiovascular surgery, free vascu-
lar grafts are often stored for short periods (hours) at
temperatures between 4°C and room temperature in hep-
arinized blood, Ringer solution, or physiological saline.1-3
In this case of short storage, the main challenge is to inhibit
activation of the endothelium, which can lead to chronic
inflammation and an obliterative lesion followed by graft
occlusion.9 In other cases, allografts are stored for days in
preservation solutions at 4°C for the use in revasculariza-
w of
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vascular grafts.4,5,10 Cold-stored vascular allografts are also
used in transplantation medicine, either as an extension if
the anatomical findings suspected preoperatively can not be
confirmed during surgery or if postoperative vascular com-
plications occur. For these applications, blood vessels are
usually stored in the same preservation solutions that are
used for organ storage, such as histidine-tryptophan-
ketoglutarate solution (HTK) and University of Wisconsin
solution (UW).11 This storage is done under hypothermic
conditions to minimize cell injury. However, hypothermia
itself injures cells during cold storage, also in preservation
solutions.12-14
It has generally been thought that hypothermia inhibits
the Na/K ATPase with subsequent intracellular accu-
mulation of sodium followed by chloride influx and cell
swelling,15-17 and the aforementioned solutions were de-
signed many years ago to counteract these alterations of
cellular ion homeostasis.15,18 However, recent studies have
shown that several cultured cell types, including endothelial
cells, do not show an increase in intracellular sodium con-
centration during cold incubation.19,20 Nevertheless, they
suffer strong hypothermic injury, which is mediated by an
Scheme. Floiron-dependent formation of reactive oxygen species(ROS); the formation of (highly) reactive species is trig-
gered by a cold-induced increase in the cellular chelatable
(or “free”), “redox-active” iron pool.12-14,21 The injury
can thus be inhibited by iron chelators while the composi-
tions of organ preservation solutions that are currently in
clinical use do not address this mechanism.22 This iron-
dependent mechanism of cold-induced cell injury, how-
ever, has so far only been shown in isolated cells. Hypoth-
esizing that this injury might also occur in intact vessels, we
here assessed the impact of iron chelators on endothelial
survival in stored intact vessels, and then continued to
optimize the hypothermic storage of blood vessels further
by optimizing the composition of the base solution.
MATERIALS AND METHODS
Using porcine aortae, the time course of vascular endo-
thelial cell injury and its iron-dependence were assessed
(Scheme). Thereafter, the base solution was optimized
(with regard to buffer, pH, main cation, main anion, ionic
strength). Then, the chelator type and concentration were
optimized and the base solution retested with optimized
chelator concentrations. Finally, the optimized solution
the protocol.was compared with currently used solutions.
ise.
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provided by Dr F. Köhler Chemie (Alsbach-Hähnlein, Ger-
many), UW solution was from BMS (Princeton, New Jer-
sey), and supplemented with 200,000 U/L benzylpenicil-
lin, 40 IU/L insulin and 16 mg/L dexamethasone.
Perfadex was purchased from Vitrolife (Kungsbacka, Swe-
den). The fluorescent dyes tetramethylrhodamine methyl ester
(TMRM), propidium iodide (PI), and 5-(and –6)-carboxy
SNARF-1, acetoxymethyl ester, acetate (SNARF-1) were
purchased from Molecular Probes (Leiden, the Netherlands);
Hoechst 33342 was from Sigma-Aldrich (Taufkirchen, Ger-
many), deferoxamine mesylate (Desferal) from Novartis
Pharma (Nuremberg, Germany).
Porcine aortic segments. Porcine aortae were ob-
tained from the local abattoir within 20 to 30 minutes of
death by exsanguination after electrical stunning and trans-
ported to the laboratory within 30 minutes. The aortae
were transported in Hanks’ balanced salt solution (HBSS) 
glucose (10 mmol/L) at room temperature. In the labo-
ratory, aortae were freed from surrounding tissue, and
extensively rinsed with sterile HBSS glucose (room tem-
perature). Thereafter, the thoracic aorta was opened longi-
tudinally, the posterior quarter of the circumference ex-
cised, and the aorta cut into segments of approximately 2
Table. Composition of the solutions
HTK Sol. 1 Sol. 2 Sol. 3 Sol. 4 So
Cl- 50 8.1 8.1 8.1 95.1 9
-Ketoglutarate 1 2 2 2 2
Aspartate — 8 7.5 7.5 7.5





 — 1 1 1 1
SO
4
2 — 1 1 1 1
Na 15 16 16 103 103 10
K 10 6 6 6 6
Mg2 4 6 6 6 6
Ca2 0.015 0.05 0.05 0.05 0.05
Histidine 198 3 — — — —
N-Acetylhistidine — 30 — — — 3
MOPS — — 25 25 25 —
Glycine — 20 20 20 20 2
Alanine — 10 10 10 10 1
Tryptophan 2 2 2 2 2
Sucrose — 182 190.5 16.5 16.5 1
Raffinose — — — — — —
Mannitol 30 — — — — —
HAES — — — — — —
Dextran — — — — — —
Allopurinol — — — — — —
Adenosine — — — — — —
GSH — — — — — —
Insulin — — — — — —
Dexamethasone — — — — — —
Penicillin — — — — — —
Glucose — 10 10 10 10 1
pH 7.2 7.0 7.0 7.0 7.0
Osmolarity
(mosm/L) 310 305.2 305.2 305.2 305.2 30
Concentrations of all compounds are given in mmol/L unless stated otherwcm length. These segments were stored in sterile polypro-pylene jars (Kartell, Milan, Italy) with 25 mL of the estab-
lished solutions or one of 10 modified solutions prepared in
our laboratory (Table), with or without deferoxamine
and/or LK 614, at 4°C for 2 to 21 days (Scheme). All
solutions were supplemented with penicillin (50 U/mL)
and streptomycin (50 g/mL). If, after storage, there was
any evidence of bacterial growth (turbidity of the solution,
film on the surface of the solution or the vessel, smell or
microscopical evidence of bacteria), the whole experiment
was discarded (ie, all aortic segments obtained on that day
from the slaughterhouse were discarded), and re-done.
Determination of endothelial cell death. Part of the
cold-stored segments were assayed immediately after cold
storage, part after rewarming in HBSS  glucose (10
mmol/L) for 3 hours. The percentage of dead (ie, pro-
pidium iodide-positive) endothelial cells was assessed
by “intravital” fluorescence microscopy. Segments were
stained with propidium iodide (5 g/mL, 5 minutes) and
Hoechst 33342 (1 g/mL, 15 minutes) in HBSS glucose,
carefully pinned, endothelial side upside, on small rubber
plates, and placed in jars filled with HBSS  glucose. The
vascular endothelium was assessed with an upright fluores-
cence microscope (Axiotech, Zeiss, Oberkochen, Germany)
with a water immersion objective (Achroplan 40x, Zeiss) at
Sol. 6 Sol. 7 Sol. 8 Sol. 9 Sol. 10 UW Perfadex
94.1 94.1 103.1 103.1 97.1 — 142
2 2 2 2 2 — —
8 8 5 5 5 — —
— — — — — 100 —
1 1 1 1 1 25 0.8
1 1 — — — 5 0.8
103 16 16 104 16 29 138
6 93 93 5 93 125 6
6 6 8 8 8 5 0.8
0.05 0.05 0.05 0.05 0.05 — —
— — — — — — —
30 30 30 30 30 — —
— — — — — — —
5 5 10 10 10 — —
— — 5 5 5 — —
2 2 2 2 2 — —
37 37 20 20 26 — —
— — — — — 30 —
— — — — — — —
— — — — — 50 g/L —
— — — — — — 50 g/L
— — — — — 1 —
— — — — — 5 —
— — — — — 3 —
— — — — — 40 U/L —
— — — — — 16 mg/L —
— — — — — 2*105 U/L —
10 10 10 10 10 — 5
7.0 7.0 7.0 7.0 7.4 7.4 7.4

















5.2exc.  365 12.5 nm, em. 515 nm.
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potential. The mitochondrial membrane potential was as-
sessed after staining samples with TMRM. After 150 min-
utes rewarming (37°C, in HBSS  glucose), TMRM (500
nmol/L) was added, after 30 minutes HBSS glucose was
renewed and, for maintenance, TMRM (250 nmol/L)
added. The segments were carefully placed, endothelial side
downside, into incubation chambers with coverglass bot-
tom. Fluorescence of the endothelial cell mitochondria was
assessed using an inverted confocal microscope (LSM 510,
Zeiss), 90 m pinhole (giving 0.7 m confocal optical
slices), at exc.  543 nm, em.  585 nm.
Platelet adhesion. Human platelets were isolated
from citrate blood as described by McNicol et al.23 The
platelets were resuspended in platelet buffer and loaded
with 2 mol/L SNARF-1 for 60 minutes at 37°C, pelleted
at 2000 x g for 12 minutes, and resuspended in platelet
buffer. Cold-stored aortic segments were rewarmed for 150
minutes in HBSS  glucose and then incubated with
platelet buffer with SNARF-1-stained platelets (410 
106 platelets/mL) for another 30 minutes at 37°C. There-
after, segments were washed vigorously with HBSS 
glucose and adherent platelets in five visual fields were
counted under an upright fluorescence microscope (as de-
scribed above) at exc.  543 nm, em.  590 nm using a
water immersion objective (Achroplan 63x, Zeiss).
Statistics. All assays were performed with four or five
segments (cf. figures), each obtained from a different aorta,
Fig 1. Occurrence of cold-induced injury. Porcine aortic seg-
ments were stored in histidine-tryptophan-ketoglutarate (HTK)
solution (white bars) or in HTK solution supplemented with 1
mmol/L deferoxamine (grey bars), for 2 to 14 days at 4°C and
thereafter immediately stained with propidium iodide (PI; hatched
part of the bars) or rewarmed in HBSS glucose (10 mmol/L) for
3 hours and then stained with propidium iodide (non-hatched part
of the bars). Vessel segments 0 days (control) were not cold-stored
but kept, analogous to “rewarming”, for 3 hours at 37°C. Data
shown are means  SD of five aortic segments (each from a
different aorta) with five visual fields of each segment counted.harvested on a different day from a different animal. Dataare expressed as means  SD. Data obtained from two
groups were compared by means of Student t test and
comparisons among multiple groups were performed using
an analysis of variance (ANOVA) with Bonferroni post hoc
comparisons. A P value of	 .05 was considered significant.
RESULTS
Iron-dependence of the storage injury to the endo-
thelium of porcine aortic segments. When porcine aortic
segments were stored in HTK solution at 4°C for 14 days,
28  17% of endothelial cells lost viability during cold
storage itself (Fig 1). During subsequent rewarming in
HBSS  glucose, this injury increased to 66  7%. The
cold-induced injury was clearly dependent on the duration
of hypothermia exposure, increasing from 2 to 14 days of
cold storage. When HTK solution was supplemented with
the iron chelator deferoxamine (1 mmol/L), however, the
percentage of dead endothelial cells was markedly de-
creased both after cold storage and after subsequent re-
warming (Fig 1).
When HBSS  glucose or modified HTK solutions
(solutions 1 through 4; compositions cf. Table) were used
for cold preservation, the addition of deferoxamine yielded
similar protection, showing that this effect of the chelator is
independent of the preservation solution used (Fig 2).
Optimization of the base solution. We recently used
Fig 2. Inhibition of endothelial injury after cold storage in differ-
ent solutions by the iron chelator deferoxamine. Porcine aortic
segments were stored in histidine-tryptophan-ketoglutarate
(HTK) solution, HBSS  10 mmol/L glucose (HBSSG) and
solution 1, 2, 3, and 4 (see Table) supplemented (grey bars) or not
(white bars) with the iron chelator deferoxamine (1 mmol/L), for
14 days at 4°C and thereafter immediately stained with propidium
iodide (hatched part of the bars) or rewarmed in HBSS  glucose
(10 mmol/L) and then stained with propidium iodide (non-
hatched part of the bars). Data shown are means SD of four aortic
segments (each from a different aorta) with five visual fields of each
segment counted. * Significantly different to incubation without
iron chelator, P 	 .05. # Significantly different to chloride-poor
control (solution 3), P 	 .05.a modified HTK solution for experimental liver preserva-
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we here assessed whether a similarly modified solution,
adjusted for the different requirements of small tissue stor-
age, also improves the storage of isolated vessels. In partic-
ular, this modified HTK solution, which contains the buffer
N-acetylhistidine instead of histidine, and the amino acids
glycine, alanine, and aspartate, was further modified for
small tissue storage by decreasing the buffering capacity.
The osmotic gap arising from decreasing buffer concentra-
tions was either filled by sucrose or by increasing the
concentrations of cations and anions, ie, of sodium or
potassium and of chloride or lactobionate. In order to
ascertain that the new buffer N-acetylhistidine does not
exert adverse effects, this buffer was replaced in part of the
solutions by the Goods’ buffer MOPS (solution 2, 3, and 4;
see Table). In the beginning, these modified HTK solu-
tions were used with and without deferoxamine (1 mmol/
L), later all solutions were only used with deferoxamine.
When aortic segments were stored in an ion-poor, high
sucrose solution with N-acetylhistidine as buffer system
(solution 1), with or without deferoxamine, at 4°C for 14
days, endothelial cell viability was slightly better than after
the respective storage in HTK solution (Fig 2). Solution 2,
containing MOPS as buffering system, yielded similar re-
sults as the N-acetylhistidine-buffered solution in the pres-
ence as well as in the absence of deferoxamine.
When sucrose was replaced by sodium lactobionate
(solution 3), endothelial cell viability was nearly identical in
the absence of the iron chelator, and there appeared to be a
tendency for lower injury (lower rewarming injury) in
solution 3 (compared with solution 2) in the presence of
the chelator (Fig 2). However, when sucrose was replaced
by sodium chloride (solution 4), vascular endothelial cell
survival was strongly increased both in the absence and in
the presence of the iron chelator.
As the injury in this sodium chloride-based solution
was, in the presence of the iron chelator, decreased to only
10  1% after 2 weeks cold storage plus rewarming, we
prolonged the cold storage time to 3 weeks for further
optimization. With 3 weeks of storage, endothelial cell
death in the MOPS-buffered, sodium chloride-based solu-
tion 4 with deferoxamine was 30 4% after rewarming and
did neither differ significantly when MOPS was replaced by
N-acetylhistidine (solution 5; data not shown), nor when,
in parallel to alterations of the “parent” organ preservation
solution, glycine, and alanine concentrations were de-
creased in this N-acetylhistidine-buffered, sodium chloride-
based solution (solution 6). However, when sodium was
then replaced by potassium (solution 7), endothelial cell
injury could be further decreased (Fig 3).
Optimization of iron chelators and their concen-
trations. Using the thus far best optimized solution (so-
lution 7), we now varied the iron chelators and their
concentrations. The well known hydrophilic iron chelator
deferoxamine is poorly membrane permeable. Therefore,
we used, in addition, LK 614, a new lipophilic hydroxamic
acid derivative (see Fig 3), hypothesizing that LK 614
permeates cell membranes more easily, chelating intracel-lular “redox-active” iron in the early period of cold storage.
LK 614 in a concentration of 50 mol/L and even in a
concentration of 20 mol/L yielded a significantly better
protection than 1 mmol/L deferoxamine (Fig 3). Combin-
ing 20 mol/L LK 614 with the 1 mmol/L deferoxamine
used so far, however, was less efficient than using 20
mol/L LK 614 alone, suggesting some degree of toxicity.
Therefore, we decreased the concentration of deferox-
amine and obtained optimal protection with 20 mol/L
LK 614 and 0.1 mmol/L deferoxamine with only 10 2%
of endothelial cells being dead after 21 days of cold storage
and subsequent rewarming.
Further testing of base solutions with the opti-
mized chelator concentrations. The so far best base so-
lution (solution 7) with optimized chelator concentrations
(0.1 mmol/L deferoxamine  20 mol/L LK 614) was
then tested against an “updated” solution with slight mod-
ifications of the amino acid concentrations (solution 8;
Fig 3. Effect of potassium and optimization of iron chelators/
iron chelator concentrations. Porcine aortic segments were stored
in histidine-tryptophan-ketoglutarate (HTK) solution and in solu-
tion 6 and 7 supplemented with the iron chelator deferoxamine
(def.), and in solution 7 with different concentrations of deferox-
amine and/or LK 614, a new lipophilic hydroxamic acid deriva-
tive, for 21 days at 4°C. All segments were rewarmed at 37°C in
HBSS  glucose (10 mmol/L) for 3 hours and then stained with
propidium iodide. Data shown are means  SD of four aortic
segments (each from a different aorta) with five visual fields of each
segment counted. * Significantly different to incubation in HTK
solution, P	 .05. # Significantly different to incubation in solution
7  1 mmol/L deferoxamine, P 	 .05.modification again triggered by a modification of the “par-
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chloride-based variant of this solution (solution 9), which
both showed no difference in endothelial cell viability after
storage for 21 days at 4°C and rewarming in HBSS 
glucose (37°C, 3 hours; Fig 4). Raising the pH to 7.4
(solution 10), in contrast, resulted in inferior cell viability
compared with solution 8.
Comparison of the best solutions with solutions
currently in clinical use. Compared with the solutions
currently used clinically, ie, HTK solution, physiological
saline, Perfadex, and UW solutions, the solutions 7, 8, and
9 with the optimized concentrations of the iron chelators
(0.1 mmol/L deferoxamine  20 mol/L LK 614)
showed considerably better endothelial cell survival (Figs 3
and 4).
Mitochondrial membrane potential. The mitochon-
drial membrane potential of the endothelial cells was best
preserved after cold storage in solution 8 with optimized
chelator concentrations (Figs 5 and 6), followed by UW
solution. Mitochondrial membrane potential after 14 days
cold storage in solution 8 plus chelators was even main-
tained better than after 7 days of cold storage in any other
solution. Of note, the potassium-rich solution 8 preserved
the mitochondrial membrane potential also significantly
Fig 4. Comparison between the new solutions and further solu-
tions used in clinical practice. Porcine aortic segments were stored
in Perfadex and University of Wisconsin (UW) solution and in the
new solutions 7, 8, 9, and 10 with optimized concentrations of the
iron chelators (0.1 mmol/L deferoxamine, def., 20 mol/L LK
614) for 21 days at 4°C, rewarmed in HBSS  glucose (37°C, 3
hours) and then stained with propidium iodide. Data shown are
means  SD of four aortic segments (each from a different aorta)
with five visual fields of each segment counted. * Significantly
different to UW, Perfadex and physiological saline, P 	 .05.
# Significantly different to the respective solution with pH 7.4
(solution 10), P 	 .05.better than the respective sodium-rich solution (solution 9)and the respective solution with pH 7.4 (solution 10, Fig
6). Storage in physiological saline or Perfadex solution or in
HTK solution with or without the iron chelator deferox-
amine yielded no adequate protection against the loss of
mitochondrial membrane potential.
Platelet adherence. When porcine aortic segments
were stored in HTK or Perfadex solutions or in solution
8  0.1 mmol/L deferoxamine  20 mol/L LK 614 for
14 days at 4°C and subsequently rewarmed in HBSS 
glucose, SNARF-1-stained platelets adhered in significantly
higher numbers to segments stored in HTK solution
(645  95/visual field) than to segments stored in Perfa-
dex solution (239  62/visual field) or in solution 8 with
optimized chelator concentrations (130 51/visual field);
solution 8 plus chelators was slightly, but not significantly
better than Perfadex solution.
DISCUSSION
The results presented show that the endothelium of
porcine aortic segments suffers an iron-dependent injury
induced by hypothermia. Iron chelators provide protection
against this injury, and further protection can be achieved
by optimizing the base solution, so that altogether, vascular
endothelial cell injury can be markedly decreased.
Cold-induced iron-dependent injury. Cold-induced
injury has been shown to occur in isolated cells including
endothelial cells.12-14,21,25 Here, a similar type of injury,
that was iron-dependent, dependent on the duration of the
cold storage period, and enhanced during rewarming (Fig
1) was found to occur to the endothelium of porcine aortic
segments in all solutions tested (Fig 2), although the
progress of injury in porcine aortic endothelium of intact
vessel segments was slower than that of isolated porcine
aortic endothelial cells (U. Rauen, T. Noll, T. Wille, H. de
Groot, 2004/2006, unpublished data); with regard to
results from cultured cells, the iron ions responsible likely
belong to the so-called “free,” “chelatable,” or “redox-
active” iron pool.12,21 As in isolated cells,12 mitochondria
were a target of this cold-induced injury, as there was a loss
of mitochondrial membrane potential, which could be
inhibited by optimizing the base solution and adding iron
chelators to the preservation solutions (Figs 5 and 6).
Sodium and cold-induced injury. Hypothermic in-
jury is often attributed to the inhibition of the Na/K
ATPase. An influx of sodium, no longer counterbalanced
by the Na/K ATPase, followed by an influx of chloride
and water was thought to lead to cellular swelling and
subsequent injury.15-17 However, recent results have
shown that these old concepts might need some reevalua-
tion: there was no increase in the cytosolic sodium concen-
tration or the cellular sodium content of different cell types
and sodium-free solutions did not prevent hypothermic
injury.19,20
In line with the latter results, sodium did not play a
major role in hypothermic endothelial injury in the current
study, as evidenced by comparing solutions 2 and 3 (Fig 2).
The discrepancy to the old concepts might be due to the
fact that the old studies suggesting a major role of cellular
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rewarming. Porcine aortic segments (control, A) were stored in solution 8 with 0.1 mmol/L deferoxamine  20
mol/L LK 614 (B), University of Wisconsin solution (C) or histidine-tryptophan-ketoglutarate solution (D) for 7
days, or in solution 8 with 0.1 mmol/L deferoxamine 20 mol/L LK 614 (E) for 14 days at 4°C and then rewarmed
in HBSS 10 mmol/L glucose at 37°C for 3 hours. Mitochondrial membrane potential was assessed by laser scanning
microscopy after staining with tetramethylrhodamine methyl ester (TMRM).
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hypoxia (for discussion see Fuckert et al),19 not pure hypo-
thermia. However, a minor role of sodium might still be
present as, in the presence of iron chelators, solutions, in
which sodium (solution 6) was replaced by potassium (so-
lution 7) yielded better endothelial cell survival/function.
Role of potassium. For endothelial cells, the superior
preservation by a potassium-rich solution (solution 7 vs
solution 6) is astonishing (Fig 3), as most studies suggest
that hyperkalemia has detrimental effects on the endothe-
lium. However, most studies about the effect of potassium
on vascular endothelium compared different complex pres-
ervation solutions (with differences in pH, osmolarity
and/or ion composition, and osmolytes) and did not
clearly discriminate the effect of potassium from other
potential injurious mechanisms.26-28 Although in the opti-
mized solution, the advantage of potassium (solution 8 vs
solution 9) was no longer evident in endothelial cell survival
(Fig 4), the potassium-rich solution still provided the su-
Fig 6. Maintenance of mitochondrial membrane potential of en-
dothelial cells of porcine aortae after cold storage and rewarming.
Porcine aortic segments were stored in histidine-tryptophan-
ketoglutarate (HTK) solution, HTK  1 mmol/L deferoxamine,
physiological saline, Perfadex, University of Wisconsin (UW) and
three modified solutions (solution 8, 9, and 10, all three with
optimized concentrations of iron chelators; 0.1 mmol/L deferox-
amine, def.,  20 mol/L LK 614) for 7 or 14 days at 4°C. After
3 hours of rewarming in HBSS  glucose, the mitochondrial
membrane potential of the segments was assessed after staining the
aortic segments with the fluorescent dye tetramethylrhodamine
methyl ester (TMRM). The amount of mitochondria with main-
tained membrane potential is given in % of non-stored control
segments. Data shown are means  SD of four aortic segments.
* Significantly different to all solutions except UW, P 	 .05.
# Significantly different to all solutions, P 	 .05.perior maintenance of mitochondrial function (Fig 6).Role of chloride. Chloride-rich solutions showed a
significantly better endothelial cell survival after cold stor-
age (Fig 2, compare solutions 3 and 4), which is in line with
recent results in isolated porcine aortic endothelial cells and
in cultured liver endothelial cells (T. Wille, H. de Groot, U.
Rauen, 2006, unpublished data). Chloride, however, ap-
pears to be protective only in some cell types, as it impairs
survival in isolated rat hepatocytes at concentrations above
40 to 50 mmol/L.22 The molecular basis of this protective
effect of chloride is not yet clear.
Iron chelators. The hydroxamic acid derivative LK
614 was effective at fairly low concentrations, suggesting
that it has indeed a better membrane permeability than
deferoxamine. The aromatic ring confers sufficient lipophi-
licity to the molecule to allow membrane permeability, the
methylation of the hydroxamic acid group is important to
avoid toxicity, and the two methoxy groups at the aromatic
ring improve iron chelation (U. Rauen, W. Bruns, H. de
Groot, 2006, unpublished results). The combination of
low concentrations of the hydrophilic chelator deferox-
amine and the new lipophilic iron chelator proved advan-
tageous (Fig 3). However, these results also show that high
concentrations of potent iron chelators, used in combina-
tions, may have toxic effects, most likely by intracellular
iron starvation.29
Base solution. In our optimized solution, we used
N-acetylhistidine as buffering system as histidine is a buffer
with a pK value in the optimal range but also with toxic
effects.30 N-substituted histidine derivatives do not show
this toxicity but maintain the buffering power, and of these,
N-acetylhistidine is also a natural compound. The buffer
capacity used for vessel storage was lower compared with a
solid organ preservation solution as the relative volume of
solution, the tissue is exposed to, is far higher. Aspartate
and -ketoglutarate were added to allow the provision of
intermediates of the citric acid cycle, whereas glucose was
added as substrate for the highly glycolytic endothelial
cells.31 The pH of the solution was set at 7.0, as a mild
acidosis shows protection against several types of cell injury
(Fig 4);32,33 the preferable cation proved to be potassium,
the preferable anion chloride (see above). Glycine and the
related amino acid alanine were added because of their
known membrane-stabilizing effect.33-35
Platelet adherence. Cold storage of vascular endothe-
lial cells has been shown to induce increased adhesion of
platelets,36 and storage of vessels has been shown to disrupt
the endothelial monolayer.37,38 Both might lead to throm-
bosis and graft occlusion, which could result in the loss of
the organ/tissue supplied by the grafted vessel.39,40 In
solution 8 with 0.1 mmol/L deferoxamine  20 mol/L
LK 614, the platelet adherence was significantly reduced
compared with HTK solution, indicating lower thrombo-
genicity.
Clinical applicability. The data presented suggests
the use of storage solutions containing a membrane-permeable
iron chelator, best in a base solution simulating solution 8,
for the cold storage of vascular grafts. Currently, however,
neither such base solution nor the new chelator LK 614 is
JOURNAL OF VASCULAR SURGERY
February 2008430 Wille et alavailable. On the other hand, the benefit of this solution for
vascular storage needs to be verified using other vessels,
including human vessels, and additional parameters of vas-
cular function such as vascular reactivity to vasoactive sub-
stances, needs to be evaluated before the solution can really
be recommended for clinical applications. Currently, solu-
tion 8 with 0.1 mmol/L deferoxamine and 20 mol/L LK
614 is therefore being tested in other vascular models and
in standard models of vascular reactivity; thereafter, its use
should be tested in vascular grafts used in an animal model.
If positive results are obtained, it is envisaged to obtain
permission for its clinical use.
CONCLUSION
Cold-induced injury to the endothelium of porcine
aortic segments is, as the injury to cultured endothelial
cells, mediated by chelatable iron. Thus, iron chelators, but
also optimized base solutions, are options to improve the
storage of vascular tissue. The optimized preservation so-
lution developed here, ie, solution 8 with 0.1 mmol/L
deferoxamine  20 mol/L LK 614, should now be
further evaluated for potential clinical use.
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